These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 1696841

  • 1. Effects of various recombinant human hemopoietic growth factors (rhEpo, rhG-CSF, rhGM-CSF, rhIl-3) on the growth of peripheral blood progenitor cells (BFU-E, CFU-GM).
    Serke S, Huhn D.
    Blut; 1990 Jul; 61(1):25-9. PubMed ID: 1696841
    [Abstract] [Full Text] [Related]

  • 2. Effect of recombinant human interleukin 3, granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor on human BFU-e in serum-free cultures.
    Misago M, Chiba S, Kikuchi M, Tsukada J, Sato T, Oda S, Eto S.
    Int J Cell Cloning; 1989 Jan; 7(1):39-49. PubMed ID: 2465360
    [Abstract] [Full Text] [Related]

  • 3. Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high-dose cyclophosphamide and hematopoietic growth factors.
    Siena S, Bregni M, Bonsi L, Sklenar I, Bagnara GP, Bonadonna G, Gianni AM.
    Exp Hematol; 1993 Nov; 21(12):1583-90. PubMed ID: 7691640
    [Abstract] [Full Text] [Related]

  • 4. Stimulation of human hematopoietic progenitor cell proliferation and differentiation by recombinant human interleukin 3. Comparison and interactions with recombinant human granulocyte-macrophage and granulocyte colony-stimulating factors.
    Ottmann OG, Abboud M, Welte K, Souza LM, Pelus LM.
    Exp Hematol; 1989 Feb; 17(2):191-7. PubMed ID: 2463933
    [Abstract] [Full Text] [Related]

  • 5. Effects of recombinant human granulocyte colony stimulating factor and granulocyte-monocyte colony stimulating factor on in vitro hemopoiesis in the myelodysplastic syndromes.
    Nagler A, Ginzton N, Negrin R, Bang D, Donlon T, Greenberg P.
    Leukemia; 1990 Mar; 4(3):193-202. PubMed ID: 1690318
    [Abstract] [Full Text] [Related]

  • 6. The in vitro effects of granulocyte and granulocyte-macrophage colony-stimulating factor on interleukin-3-dependent proliferation of human neonatal circulating progenitor cells.
    Bedford Russell AR, Davies EG, Gibson FM, Gordon-Smith EC.
    Pediatr Res; 1995 May; 37(5):630-3. PubMed ID: 7541523
    [Abstract] [Full Text] [Related]

  • 7. Antagonistic effects of interleukin 6 and G-CSF in the later stage of human granulopoiesis in vitro.
    Katayama K, Koizumi S, Ueno Y, Ohno I, Ichihara T, Horita S, Miyawaki T, Taniguchi N.
    Exp Hematol; 1990 Jun; 18(5):390-4. PubMed ID: 1692536
    [Abstract] [Full Text] [Related]

  • 8. In vitro study of erythropoiesis in patients with aplastic anemia and myelodysplastic syndromes: a possible tool for prospective determination of the clinical effectiveness of growth factors.
    Aoki A, Shibata A.
    Hematol Pathol; 1992 Jun; 6(3):143-53. PubMed ID: 1429342
    [Abstract] [Full Text] [Related]

  • 9. Three quantitative assays for human erythroid burst-promoting activity of recombinant growth factors and of omentum-conditioned medium.
    Sasaki H, Koiso Y, Ikuta K, Kajigaya Y, Funabiki T, Matsuyama S.
    Exp Hematol; 1990 Feb; 18(2):84-8. PubMed ID: 2406158
    [Abstract] [Full Text] [Related]

  • 10. Human granulocyte-macrophage colony-stimulating factor (GM-CSF) stimulates immature marrow precursors but no CFU-GM, CFU-G, or CFU-M.
    Bot FJ, van Eijk L, Schipper P, Löwenberg B.
    Exp Hematol; 1989 Mar; 17(3):292-5. PubMed ID: 2645158
    [Abstract] [Full Text] [Related]

  • 11. Priming with recombinant human hematopoietic cytokines before bone marrow harvest expands in vivo and enhances ex vivo recovery of myeloid progenitors in short-term liquid cultures.
    Johnsen HE, Jensen L, Gaarsdal E, Hansen PB, Ersbøll J, Hansen NE.
    Exp Hematol; 1994 Jan; 22(1):80-6. PubMed ID: 7506675
    [Abstract] [Full Text] [Related]

  • 12. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [Abstract] [Full Text] [Related]

  • 13. Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor.
    Broxmeyer HE, Cooper S, Williams DE, Hangoc G, Gutterman JU, Vadhan-Raj S.
    Exp Hematol; 1988 Aug; 16(7):594-602. PubMed ID: 3260558
    [Abstract] [Full Text] [Related]

  • 14. Effects of five recombinant hematopoietic growth factors on enriched human erythroid progenitors in serum-replaced cultures.
    Mitjavila MT, Natazawa M, Brignaschi P, Debili N, Breton-Gorius J, Vainchenker W.
    J Cell Physiol; 1989 Mar; 138(3):617-23. PubMed ID: 2647773
    [Abstract] [Full Text] [Related]

  • 15. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
    Lemoli RM, Fortuna A, Fogli M, Motta MR, Rizzi S, Benini C, Tura S.
    Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
    [Abstract] [Full Text] [Related]

  • 16. The in vitro effect of high-dose recombinant human erythropoietin on granulocyte-macrophage colony production in premature infants using a defined serum deprived cell culture system.
    Ward CS, Westwood NB, Emmerson AJ, Pearson TC.
    Br J Haematol; 1992 Jul; 81(3):325-30. PubMed ID: 1382542
    [Abstract] [Full Text] [Related]

  • 17. Polycythemia vera. II. Hypersensitivity of bone marrow erythroid, granulocyte-macrophage, and megakaryocyte progenitor cells to interleukin-3 and granulocyte-macrophage colony-stimulating factor.
    Dai CH, Krantz SB, Dessypris EN, Means RT, Horn ST, Gilbert HS.
    Blood; 1992 Aug 15; 80(4):891-9. PubMed ID: 1498332
    [Abstract] [Full Text] [Related]

  • 18. Sequential in vivo treatment with two recombinant human hematopoietic growth factors (interleukin-3 and granulocyte-macrophage colony-stimulating factor) as a new therapeutic modality to stimulate hematopoiesis: results of a phase I study.
    Ganser A, Lindemann A, Ottmann OG, Seipelt G, Hess U, Geissler G, Kanz L, Frisch J, Schulz G, Herrmann F.
    Blood; 1992 May 15; 79(10):2583-91. PubMed ID: 1586711
    [Abstract] [Full Text] [Related]

  • 19. Effects of recombinant growth factors on radiation survival of human bone marrow progenitor cells.
    Uckun FM, Gillis S, Souza L, Song CW.
    Int J Radiat Oncol Biol Phys; 1989 Feb 15; 16(2):415-35. PubMed ID: 2466026
    [Abstract] [Full Text] [Related]

  • 20. Effect of in vivo treatment with rh GM-CSF on in vitro growth of haematopoietic progenitors in patients with myelodysplastic syndromes.
    Visani G, Tosi P, Finelli C, Gamberi B, Zauli G, Cenacchi A, Fogli M, Colombini R, Tura S.
    Haematologica; 1992 Feb 15; 77(2):142-5. PubMed ID: 1383105
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.